Why Delhi Derma Clinic

The clinic operates a calibrated dermatology consultation model rather than a procedure-funnel model. Assessment, recommendation, and care-plan ownership sit with the dermatologist; the consultation conversation produces the recommendation rather than a website-self-selection flow or a quiz funnel routing patients into pre-decided pathways. The framework deliberately calibrates to the case rather than channelling every patient toward a single high-volume signature procedure.

Dr Chetna Ghura, MBBS MD Dermatology, with Delhi Medical Council registration DMC 2851, is the lead dermatologist and clinical decision-maker for assessment and recommendation across all pathways. The framework treats medical-board postgraduate dermatology training as the credentialing floor rather than as a marketing line. The Dr Chetna Ghura page covers the wider professional profile.

MD Dermatology is the postgraduate medical degree in dermatology, venereology, and leprology after the MBBS. It reflects three years of postgraduate dermatology training under recognised teaching institutions and is the dermatology-specialist credential within Indian medical training. Short-course skin training, cosmetology certifications, and other non-postgraduate routes do not match MD-Dermatology training in either diagnostic scope or pharmacological scope.

Yes. The standard MD-Dermatology scope covers skin, hair, and nail medicine alongside selected procedural pathways for cosmetic-dermatology concerns. The framework operates the medical-dermatology layer (acne management, pigmentation pathways including melasma, hair-fall medical management, selected inflammatory and immune-mediated dermatology, mole and lesion review) alongside the procedural-cosmetology layer rather than separating them.

Indian-skin Fitzpatrick III–VI pigmented contexts shape device-parameter selection, pigmentation-pathway calibration, residual-risk discussion around post-inflammatory pigmentation, and selected procedural pathway routing. The technical framework around device parameters for pigmented Indian skin is documented at the laser safety on Indian skin page. Calibration for pigmented Indian skin is built into the standard framework, not bolted on as optional polish.

The framework states realistic outcome ranges rather than absolute outcome promises. For pigmentation pathways the realistic frame is graded clearance with maintenance dependency rather than fixed-final clearance; for laser hair reduction the realistic frame is calibrated reduction with maintenance touch-points rather than absolute lifetime hair clearance; for anti-ageing the realistic frame is supporting healthy ageing trajectory rather than reversing biological age; for acne-scar resurfacing the realistic frame is calibrated improvement against baseline rather than complete reset to scar-free skin.

Residual-risk items for each procedural pathway are discussed transparently at the consent stage and surfaced in the written plan rather than hidden as legal-defensive footnotes. The framework treats this as substantive content because patients deciding on procedural pathways need accurate-rather-than-inflated information to consent meaningfully. The safety standards page covers the framework in detail.

The framework respects patient autonomy without abandoning clinical responsibility. Where the requested procedure is appropriate the framework proceeds with calibrated parameters. Where it is not — because of skin context, prior pattern, residual-risk profile, or because foundations need to be established first — the conversation surfaces what is appropriate and why. Selected requests cannot be honoured because they fall outside what is clinically defensible. The treatment suitability philosophy page covers the framing.

The framework deliberately avoids same-day-procedure sales pressure, time-limited "act-now" promotional pricing for medical pathways, comparison-image-led advertising of clinical pathways, "permanent" outcome framing, "marvel-result" or "rapid-clearance" claims, "top-rated clinic" or "rapid-result" superlatives, fairness or skin-bleaching framing, false-urgency offers, invented slot-availability claims, fake-response-time promises, and influencer-discount or commission-driven referral promotion of clinical pathways.

Site-wide, every clinical page carries Dr Chetna Ghura's reviewer signature alongside the lastReviewed date and the schema-graph data. The editorial standards page covers the writing-and-review framework, and the medical review process page covers the dermatologist-review pathway. The framework treats accountability documentation as substantive rather than as optional polish.

The consultation visit produces a calibrated written plan covering the recommendation, the rationale connecting the assessment to the recommendation, the realistic outcome range across an evidence-based timeline, the maintenance pattern where applicable, the residual-risk profile, the per-component pricing for the recommended pathway, the proposed follow-up cadence, and any blood-work or referral routing. The patient leaves the visit with the plan and decides whether and when to proceed.

The dermatology consultation is priced at ₹1,999*. The fee covers the calibrated visit time, the clinical assessment, photographic baseline establishment where applicable, blood-work interpretation when applicable, and the written plan handed over at the close. Procedural-pathway pricing is calibrated case-by-case at the consultation rather than displayed as a website list price. The Pricing FAQs covers the framework.

A typical first-visit dermatology consultation runs around thirty-to-forty-five minutes. Visits with multi-concern complexity or extensive prior treatment history typically run longer than the standard window. The framework calibrates visit length to the case rather than to a fixed clock-driven slot.

The framework operates on a prior-appointment model rather than walk-ins, so visit time is calibrated to the case rather than to a queue. The framework does not run patient-flow on aggressive overbooking that creates significant wait. Where a meaningful delay is anticipated, the clinic communicates it. The framework does not pressure same-day-procedure decisions; consideration time is part of how decisions are arrived at well rather than rushed.

Follow-up cadence is part of the written plan from the start, calibrated to the pathway. Procedural pathways are typically reviewed at the relevant response window; maintenance pathways for hair-loss, pigmentation, and ageing trajectory run six-monthly to annually. Selected follow-ups can be supported by video format where in-person examination is not necessary. The framework treats follow-up as part of the care continuum rather than as the end of a project.

Pathway descriptions reference the standard dermatology evidence base — peer-reviewed clinical literature, established guideline frameworks, and the dermatology-specialist consensus on calibrated approaches. The framework does not over-claim novel-or-revolutionary findings; selected pathways are framed as established, others as emerging-with-calibrated-evidence, with the framing honest in either case.

Device-related claims are framed conservatively. Device categories and parameter approaches are referenced (long-pulse Nd:YAG, diode laser, Q-switched laser, fractional CO2 laser, microneedling-RF, HIFU, RF skin-tightening, cryolipolysis class) without over-claiming manufacturer or model superiority. Specific technical detail sits in the technology section pages.

The framework operates within the prevailing medical-advertising regulation in India. The framework explicitly avoids comparison-image-led advertising of clinical pathways, sponsored-influencer promotion of clinical procedures, fake comparison-image marketing, and superlative ranking claims. The editorial standards page covers the framing.

Patient autonomy is substantive in the framework. Decisions about whether and when to proceed with a pathway sit with the patient. Staged commitment, second-opinion seeking, deferral, and discontinuation are all supported within the framework where they fit the clinical calibration; none is treated as a failure. The framework prefers patients who proceed with calibrated expectations over those who commit under pressure and disengage downstream.

Where a patient has a formal concern about the care received, the conduct of the consultation, or any other aspect of the patient-clinic interaction, the formal Complaints and Grievance Redressal Policy in the policies section is the route for handling. In-pathway calibration adjustment is handled through follow-up; formal grievance handling sits in the formal policy. These two routes are distinguished by the framework.